Autoantikehitteet

Autoantikehitteet, also known as autoantigens, are proteins or other molecules that are normally produced by the body's own cells. They are recognized as foreign by the immune system, leading to the production of antibodies against them. Autoantikehitteet are a key feature of autoimmune diseases, where the immune system mistakenly attacks the body's own tissues. The most common types of autoantikehitteet include:

1. Myelin basic protein (MBP): Associated with multiple sclerosis (MS).

2. Thyroid peroxidase (TPO): Linked to Hashimoto's thyroiditis.

3. Tyrosine phosphatase (PTP): Involved in type 1 diabetes.

4. Glutamic acid decarboxylase (GAD): Associated with type 1 diabetes.

5. Insulin: Targeted in type 1 diabetes.

The immune system's response to autoantikehitteet can lead to inflammation, tissue damage, and the characteristic symptoms of autoimmune diseases. Understanding the role of autoantikehitteet is crucial for the development of targeted therapies for autoimmune disorders. Research into autoantikehitteet aims to identify specific targets for treatment, potentially leading to more effective and personalized therapies for patients with autoimmune diseases.